The CGT industry is expanding at a neck-breaking pace backed by many transformative therapies aimed at curing diseases. There are several dozens of approved therapies treating various rare cancers and genetic disorders. With thousands of therapies in development, the CGT industry has the potential to disrupt the current standards of care for certain terminal diseases and is poised for substantial growth over the next decade.
Key Tech’s expertise in developing automated medical manufacturing instruments and consumables can speed up your CGT therapy development. Backed by over 25 years of experience, Key Tech’s multidisciplinary team bring relevant design experience from many biotechnology fields, such as fluidic precision control and analysis, instrument automation, in-line analytics, sensor integration, algorithm development, and GMP.
Services for Cell & Gene Therapy Development Groups
Test Bed Development
Consumable Design
Microfluidic Services
Cell Preparation
Workflow Analysis for Ease of Use

Intuitive devices to prepare drugs for administration

Smart test beds for R&D and verification

Reliable actuation for various types of connections

Fluidic motivation of various volumes and types of fluids